Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects
Jesse Hall,1 Michael Gillen,2 Sha Liu,1 Jeffrey N Miner,1 Shakti Valdez,1 Zancong Shen,1 Caroline Lee1 1Ardea Biosciences, Inc., San Diego, CA, USA; 2AstraZeneca, Gaithersburg, MD, USA Purpose: Verinurad (RDEA3170) is a selective uric acid reabsorption inhibitor in clinical development for treatme...
Main Authors: | Hall J, Gillen M, Liu S, Miner JN, Valdez S, Shen Z, Lee C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/ppharmacokinetics-pharmacodynamics-and-tolerability-of-verinurad--peer-reviewed-article-DDDT |
Similar Items
-
Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects
by: Shen Z, et al.
Published: (2017-07-01) -
Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice
by: Ruixia Bao, et al.
Published: (2019-12-01) -
Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers
by: Gillen M, et al.
Published: (2016-11-01) -
«URAT-INDEX» – NON-INVASIVE TOOL FOR PREDICTION OF URIC ACID CONTAINING STONES
by: N. K. Gadzhiev, et al.
Published: (2018-01-01) -
The Efficacy and Mechanism of Chinese Herbal Medicines in Lowering Serum Uric Acid Levels: A Systematic Review
by: Liqian Chen, et al.
Published: (2021-01-01)